Product image of Olanzapina Viatris (Olanzapine) supplied by GNH India

Olanzapina Viatris

Active Ingredient:
Olanzapine
Origin:
EU

Olanzapina Viatris (Olanzapine)

Olanzapine, the active ingredient in Olanzapina Viatris, is an atypical antipsychotic presented as oral tablets for oral use. It is prescribed to manage symptoms of schizophrenia and bipolar I disorder in adult patients, helping to reduce psychosis and stabilize mood.

GNH India supplies Olanzapina Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this essential psychiatric medication. Olanzapina Viatris is manufactured under GMP conditions and undergoes rigorous testing before release.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Olanzapina Viatris (olanzapine) is used in the management of psychotic and mood disorders.

  • Schizophrenia: alleviates positive and negative symptoms, reducing hallucinations and delusions.
  • Bipolar I disorder (manic episodes): stabilizes mood and decreases manic symptoms.
  • Maintenance therapy for schizoaffective disorder: helps sustain remission and prevent relapse.

How It Works

  • Olanzapine exerts its therapeutic effect primarily by antagonizing dopamine D2 receptors and serotonin 5‑HT2A receptors in the central nervous system. It also exhibits affinity for histamine H1, muscarinic, and α1‑adrenergic receptors, contributing to its antipsychotic and mood‑stabilizing properties while influencing neurotransmitter balance. These actions reduce dopaminergic overactivity in mesolimbic pathways and modulate serotonergic transmission, which underlies its efficacy in psychosis and mood regulation.

Side Effects

Olanzapina Viatris may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Weight gain: increased appetite leading to weight increase.
  • Sedation: drowsiness or sleepiness.
  • Dry mouth: reduced salivation.
  • Constipation: slowed gastrointestinal motility.

Serious or Rare Side Effects

  • Neuroleptic malignant syndrome: life‑threatening reaction with fever and muscle rigidity.
  • Agranulocytosis: severe reduction in white blood cells.
  • Tardive dyskinesia: involuntary, repetitive movements.
  • Severe hyperglycemia/diabetes: marked increase in blood glucose levels.

Precautions & Warnings

When prescribing Olanzapina Viatris, clinicians should observe several safety considerations.

  • Metabolic monitoring: regularly assess weight, glucose, and lipid levels.
  • Cardiovascular assessment: evaluate blood pressure and heart rate due to orthostatic effects.
  • Diabetes risk: screen for pre‑existing diabetes and monitor glucose during therapy.
  • Seizure caution: use with care in patients with a history of seizures.
  • Elderly dementia patients: avoid use due to increased mortality risk.
  • Store at room temperature: keep in original packaging, protect from moisture.

Avoid Interactions

Olanzapina Viatris can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • CNS depressants: combined use may enhance sedation and respiratory depression.
  • CYP1A2 inhibitors (e.g., fluvoxamine): increase olanzapine plasma concentrations.
  • Anticholinergic agents: may exacerbate anticholinergic side effects.
  • QT‑prolonging drugs: increase risk of cardiac arrhythmias.
  • Lithium: concurrent use can raise risk of neurotoxicity.

Moderate Interactions (Monitor Closely)

  • CYP2D6 substrates (e.g., metoprolol): may require dose adjustment.
  • Antihypertensives: additive hypotensive effect possible.
  • Antidiabetic agents: olanzapine may alter glucose control.
  • Smoking: induces metabolism, potentially reducing drug levels.
  • Carbamazepine: enzyme induction may lower olanzapine concentrations.

Frequently Asked Questions

Olanzapina Viatris is a generic formulation of olanzapine, an atypical antipsychotic indicated for the treatment of schizophrenia and bipolar I disorder in adult patients. It helps reduce psychotic symptoms such as hallucinations and delusions, and stabilizes mood during manic episodes.

Olanzapine works by blocking dopamine D2 receptors and serotonin 5‑HT2A receptors in the brain, which reduces dopaminergic overactivity and modulates serotonergic pathways. Its additional activity at histamine, muscarinic, and adrenergic receptors contributes to its antipsychotic and mood‑stabilizing effects.

The dosage of Olanzapina Viatris is individualized. A qualified prescriber determines the appropriate amount based on the specific condition, patient response, tolerability, and other clinical factors. Dosing may be adjusted over time to achieve optimal therapeutic outcomes.

Olanzapina Viatris should be used during pregnancy or lactation only if the potential benefits outweigh the risks. Limited clinical data are available, and there is a possibility of fetal exposure or passage into breast milk. Healthcare providers should discuss potential risks with the patient.

To order Olanzapina Viatris, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details, and any required import documentation.

Olanzapina Viatris (olanzapine) belongs to the atypical antipsychotic class and is often compared with agents such as risperidone or quetiapine. Compared with typical antipsychotics, olanzapine generally has a lower risk of extrapyramidal symptoms but a higher propensity for metabolic side effects like weight gain and glucose elevation.

Olanzapina Viatris should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and avoid direct exposure to light. Do not refrigerate or freeze the tablets.

Olanzapina Viatris is supplied as oral tablets. Patients should swallow the tablet whole with water, with or without food, as directed by the prescriber. The medication is not intended for crushing, chewing, or dissolving unless specifically instructed.

Serious risks include neuroleptic malignant syndrome, a potentially fatal reaction characterized by high fever and muscle rigidity; agranulocytosis, a severe drop in white blood cells; tardive dyskinesia, which involves involuntary movements; and significant metabolic disturbances such as hyperglycemia or new‑onset diabetes.

Olanzapina Viatris should be avoided in individuals with known hypersensitivity to olanzapine or any of its excipients. It is also contraindicated in patients with severe central nervous system depression, and it should be used with caution in the elderly with dementia‑related psychosis due to an increased risk of mortality.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Olanzapine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT